QRTEA

2 members of Congress have disclosed 6 trades in QRTEA (QRTEA) via STOCK Act filings. The most recent disclosure was a sale by Donna E. Shalala on 24 June 2019. The most active traders have been Greg Gianforte (4) and Donna E. Shalala (2). Aggregate disclosed activity totals roughly $175K in purchases and $298.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for QRTEA
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for QRTEA

5 transactions
Compliance: 83%
Donna E. Shalala24 Jun 201927 Apr 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala24 Jun 201921 Jul 2020SaleStock$1,001 - $15,000N/A
Greg Gianforte13 May 201912 Jun 2019SaleStock$15,001 - $50,000N/A
Greg Gianforte13 May 201912 Jun 2019SaleStock$50,001 - $100,000N/A
Greg Gianforte23 Jan 20196 Mar 2019PurchaseStock$100,001 - $250,000N/A

See every trade

Sign in free to see the full trade history for this stock.

No overview data available for this stock

Earnings

Recent Quarters

Q3 20255 Nov
EPS$-0.20
Q2 20256 Aug
EPS$-5.60
Q1 20256 May
EPS$-0.25
Q4 202427 Feb
EPS$0.22
Miss 29.0%
Q3 20247 Nov
EPS$-0.06
Miss 166.7%
Q2 20248 Aug
EPS$0.05
Miss 28.6%
Q1 20248 May
EPS$0.04
Beat 0.0%
Q4 202328 Feb
EPS$0.22
Beat 69.2%
Q3 20233 Nov
EPS$0.10
Beat 150.0%
Q2 20234 Aug
EPS$-0.03
Miss 127.3%
Q1 20235 May
EPS$-0.05
Beat 37.5%
Q4 20221 Mar
EPS$-0.05
Miss 129.4%
Q3 20224 Nov
EPS$-0.08
Miss 214.3%
Q2 20225 Aug
EPS$0.12
Miss 14.3%
Q1 20226 May
EPS$0.15
Miss 40.0%
Q4 202125 Feb
EPS$0.40
Miss 32.2%
Q3 20214 Nov
EPS$0.30
Miss 38.8%
Q2 20216 Aug
EPS$0.54
Beat 8.0%
Q1 20217 May
EPS$0.48
Beat 45.5%
Q4 202026 Feb
EPS$1.59
Beat 109.2%
Q3 20204 Nov
EPS$0.57
Beat 35.7%
Q2 202010 Aug
EPS$0.54
Beat 10.2%
Q1 20206 May
EPS$0.27
Miss 10.0%
Q4 201925 Feb
EPS$0.68
Beat 3.0%
Q3 201911 Nov
EPS$0.42
Beat 40.0%
Q2 20197 Aug
EPS$0.48
Beat 14.3%
Q1 20199 May
EPS$0.35
Miss 7.9%
Q4 201827 Feb
EPS$0.62
Miss 15.1%
Q3 20189 Nov
EPS$0.37
Beat 15.6%
Q2 20188 Aug
EPS$0.45
Miss 2.2%
Q1 201810 May
EPS$0.49
Beat 40.0%
Q4 20171 Mar
EPS$1.11
Beat 126.5%
Q3 20179 Nov
EPS$0.26
Beat 62.5%
Q2 20178 Aug
EPS$0.25
Beat 4.2%
Q1 20179 May
EPS$0.20
Beat 33.3%
Q4 201628 Feb
EPS$0.40
Beat 2.6%
Q3 20168 Nov
EPS$0.13
Beat 0.0%
Q2 20165 Aug
EPS$0.26
Beat 13.0%
Q1 20169 May
EPS$0.18
Miss 10.0%
Q4 201528 Feb
EPS$0.46
Miss 9.8%
Q3 20154 Nov
EPS$0.33
Beat 22.2%
Q2 20155 Aug
EPS$0.24
Beat 0.0%
Q1 20158 May
EPS$0.31
Beat 40.9%
Q4 201425 Feb
EPS$0.46
Miss 6.1%
Q3 20144 Nov
EPS$0.25
Beat 31.6%
Q2 20145 Aug
EPS$0.21
Miss 22.2%
Q1 20148 May
EPS$0.22
Miss 8.3%
Q4 201328 Feb
EPS$0.31
Miss 31.1%
Q3 20135 Nov
EPS$0.17
Miss 10.5%
Q2 20136 Aug
EPS$0.21
Miss 22.2%
Q1 20138 May
EPS$0.18
Miss 10.0%
Q4 201227 Feb
EPS$0.33
Miss 21.4%
Q3 20126 Nov
EPS$0.07
Miss 58.8%
Q2 20128 Aug
EPS$0.07
Miss 69.6%
Q1 20128 May
EPS$0.16
Beat 0.0%
Q4 201123 Feb
EPS$0.48
Beat 29.7%
Q3 20118 Nov
EPS$0.02
Miss 85.7%
Q2 20119 Aug
EPS$0.30
Beat 76.5%
Q1 20116 May
EPS$0.07
Miss 46.1%
Q4 201028 Feb
EPS$0.66
Beat 164.0%
Q3 20105 Nov
EPS$0.17
Beat 240.0%
Q2 20109 Aug
EPS$0.10
Miss 9.1%
Q1 20107 May
EPS$0.51
Beat 325.0%
Q4 200925 Feb
EPS$0.32
Beat 39.1%
Q3 20099 Nov
EPS$-0.01
Miss 109.2%
Q2 20097 Aug
EPS$0.21
Beat 61.5%
Q1 20098 May
EPS$-0.10
Miss 200.0%
Q4 200825 Feb
EPS$0.11
Miss 45.0%
Q3 200830 Oct
EPS$0.06
Miss 53.9%
Q2 200811 Aug
EPS$0.15
Miss 6.3%
Q1 20088 May
EPS$0.21
Beat 61.5%
Q4 200728 Feb
EPS$0.28
Miss 3.5%
Q3 20079 Nov
EPS$0.12
Miss 7.7%
Q2 20078 Aug
EPS$0.16
Miss 5.9%
Q1 20078 May
EPS$0.14
Miss 12.5%
Q4 200628 Feb
EPS$0.28
Beat 0.0%
Q3 20066 Nov
EPS$0.17
Beat 54.5%
Q2 20069 Aug
EPS$0.18
Beat 125.0%

Dividends

Dividend History

12 Nov 2021
Amount $1.2500
27 Nov 2020
Amount $1.5000
15 Sept 2020
Amount $1.5000
28 Aug 2020
Amount $1.5000

Stock Splits

Split History

15 Oct 2014Stock Split
Ratio591:500
14 Apr 2014Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about QRTEA

Which members of Congress have traded QRTEA?
2 members of Congress have disclosed 6 trades in QRTEA (QRTEA) under the STOCK Act. The most active traders are Greg Gianforte and Donna E. Shalala.
When was QRTEA most recently disclosed by Congress?
The most recent QRTEA disclosure was a sale by Donna E. Shalala on 24 June 2019.
What is the total disclosed congressional trading volume for QRTEA?
Members of Congress have disclosed approximately $175K in QRTEA purchases and $298.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in QRTEA?
This QRTEA page updates as soon as new STOCK Act disclosures are filed for QRTEA. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.